DE3769495D1 - 2-(substituierte-imino)-6-aryl-3,6-dihydro-4-substituierte-1,5(2h)-pyrimidincarboxylsaeuren und analoga. - Google Patents
2-(substituierte-imino)-6-aryl-3,6-dihydro-4-substituierte-1,5(2h)-pyrimidincarboxylsaeuren und analoga.Info
- Publication number
- DE3769495D1 DE3769495D1 DE8787301307T DE3769495T DE3769495D1 DE 3769495 D1 DE3769495 D1 DE 3769495D1 DE 8787301307 T DE8787301307 T DE 8787301307T DE 3769495 T DE3769495 T DE 3769495T DE 3769495 D1 DE3769495 D1 DE 3769495D1
- Authority
- DE
- Germany
- Prior art keywords
- substituted
- imino
- dihydro
- aryl
- analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/832,184 US4689414A (en) | 1986-02-24 | 1986-02-24 | 2-(substituted imino)-6-aryl-3,6-dihydro-4-substituted-1,5(2H)-pyrimidinecarboxylic acids and analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3769495D1 true DE3769495D1 (de) | 1991-05-29 |
Family
ID=25260927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8787301307T Expired - Fee Related DE3769495D1 (de) | 1986-02-24 | 1987-02-16 | 2-(substituierte-imino)-6-aryl-3,6-dihydro-4-substituierte-1,5(2h)-pyrimidincarboxylsaeuren und analoga. |
Country Status (5)
Country | Link |
---|---|
US (1) | US4689414A (de) |
EP (1) | EP0234830B1 (de) |
JP (1) | JPS62221674A (de) |
CA (1) | CA1275409C (de) |
DE (1) | DE3769495D1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4728652A (en) * | 1985-05-20 | 1988-03-01 | E. R. Squibb & Sons, Inc. | 2-substituted thio or oxy-4-aryl or heterocyclo-5-carboxy-1,4-dihydropyrimidines, composition containing them, and method of using them to reduce blood pressure |
US5202330A (en) * | 1985-06-03 | 1993-04-13 | E. R. Squibb & Sons, Inc. | 2-thio or oxo-4-aryl or heterocyclo-1,5(2H)-pyrimidinedicarboxylic acid diesters and 3-acyl-5-pyrimidinecarboxylic acids and esters |
US4855301A (en) * | 1986-10-09 | 1989-08-08 | E. R. Squibb & Sons, Inc. | 1,2,3,4-Tetrahydro-6-substituted-4-aryl(or heterocyclo)-3-((substituted amino)carbonyl)-2-thioxo (or oxo)-5-pyrimidinecarboxylic acids and esters |
US4883872A (en) * | 1987-11-25 | 1989-11-28 | E. R. Squibb & Sons, Inc. | 3-oxo-1,2,4-triazolo(4,3-A) pyrimidine-6-carboxylic acid esters |
SK60097A3 (en) * | 1994-11-16 | 1998-01-14 | Synaptic Pharma Corp | Dihydropyrimidines, pharmaceutical composition containing same and use thereof |
US6268369B1 (en) | 1994-11-16 | 2001-07-31 | Synaptic Pharmaceutical Corporation | 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines |
US6228861B1 (en) | 1995-11-16 | 2001-05-08 | Synaptic Pharmaceutical Corporation | Dihydropyrimidines and uses thereof |
US6245773B1 (en) | 1996-05-16 | 2001-06-12 | Synaptic Pharmaceutical Corporation | 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines |
US6172066B1 (en) | 1996-05-16 | 2001-01-09 | Synaptic Pharmaceutical Corporation | Dihydropyrimidines and uses thereof |
US6037354A (en) | 1997-06-18 | 2000-03-14 | Merck & Co., Inc. | Alpha 1a adrenergic receptor antagonists |
US6080760A (en) * | 1997-06-18 | 2000-06-27 | Merck & Co., Inc. | Alpha 1A adrenergic receptor antagonists |
US6143750A (en) * | 1997-06-18 | 2000-11-07 | Merck & Co., Inc. | Alpha 1a adrenergic receptor antagonists |
US6214832B1 (en) | 1997-06-18 | 2001-04-10 | Merck & Co., Inc. | Bis-piperidinyl-pyrimidin-2-ones as alpha 1a adrenergic receptor antagonists |
US6057350A (en) * | 1997-06-18 | 2000-05-02 | Merck & Co., Inc. | Alpha 1a adrenergic receptor antagonists |
US6376503B1 (en) | 1997-06-18 | 2002-04-23 | Merck & Co., Inc | Alpha 1a adrenergic receptor antagonists |
US6339099B1 (en) | 1997-06-20 | 2002-01-15 | Dupont Pharmaceuticals Company | Guanidine mimics as factor Xa inhibitors |
US6063786A (en) * | 1997-11-12 | 2000-05-16 | Darwin Discovery, Ltd. | Heterocyclic compounds having MMP and TNF inhibitory activity |
GB9723905D0 (en) * | 1997-11-12 | 1998-01-07 | Chiroscience Ltd | Heterocyclic compounds having MMP and TNF inhibitory activity |
US6680323B2 (en) | 1998-12-23 | 2004-01-20 | Synaptic Pharmaceutical Corporation | Dihydropyrimidines and uses thereof |
US6274585B1 (en) | 1998-12-23 | 2001-08-14 | Synaptic Pharmaceutical Corporation | Dihydropyrimidines and uses thereof |
US6720324B2 (en) | 2000-07-05 | 2004-04-13 | Synaptic Pharmaceutical Corporation | Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof |
WO2004054986A2 (en) * | 2002-12-16 | 2004-07-01 | Astrazeneca Uk Limited | Process for the preparation of pyrimidine compounds |
WO2005007124A2 (en) * | 2003-07-23 | 2005-01-27 | Bristol-Myers Squibb Company | Substituted dihydropyrimidine inhibitors of calcium channel function |
US7166603B2 (en) * | 2003-07-23 | 2007-01-23 | Bristol-Myers Squibb Co. | Dihydropyrimidone inhibitors of calcium channel function |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4025517A (en) * | 1975-06-23 | 1977-05-24 | Mcneil Laboratories, Incorporated | 4-Oxo-2-hexahydropyrimidinylidene ureas |
NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
HUT42077A (en) * | 1985-06-03 | 1987-06-29 | Squibb & Sons Inc | Process for producing diesters of 2-tioxo- or 2-oxo-pyrimidine-1,5-dicarboxylic acid and 1-acyl-pyrimidine-5-carboxylic acids and esters |
-
1986
- 1986-02-24 US US06/832,184 patent/US4689414A/en not_active Expired - Fee Related
-
1987
- 1987-01-23 CA CA000528079A patent/CA1275409C/en not_active Expired - Fee Related
- 1987-02-16 EP EP87301307A patent/EP0234830B1/de not_active Expired - Lifetime
- 1987-02-16 DE DE8787301307T patent/DE3769495D1/de not_active Expired - Fee Related
- 1987-02-23 JP JP62039973A patent/JPS62221674A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA1275409C (en) | 1990-10-23 |
EP0234830B1 (de) | 1991-04-24 |
US4689414A (en) | 1987-08-25 |
JPS62221674A (ja) | 1987-09-29 |
EP0234830A1 (de) | 1987-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3769495D1 (de) | 2-(substituierte-imino)-6-aryl-3,6-dihydro-4-substituierte-1,5(2h)-pyrimidincarboxylsaeuren und analoga. | |
NL940006I2 (nl) | 1,2-Benzuisoxazol-3-yl-en 1,2-benzisothiazol-3-yl-derivaten. | |
FI883596A0 (fi) | Epipodofyllotoxinglukosid-4' -fosfatderivat. | |
FI872653A (fi) | Fiberhaltig soetsakskomposition med mjuk textur. | |
NO881121D0 (no) | 5-substituerte chinolon- og naftyridonkarboksylsyrederivater. | |
DE3775802D1 (de) | 2-(4'-alkoxyphenyl)-5-alkylpyridine. | |
DE3873797D1 (de) | E-prostaglandine und ihre anti-ulcusanwendung. | |
DE3766514D1 (de) | 1,2,3,4-tetrahydro-6-substituierte-4-aryl(oder heterocyclo)-3-substituierte-2-thioxo(oder oxo)-5-pyrimidincarboxylsaeuren und -ester. | |
DE68923913D1 (de) | Neplanocinderivate. | |
DE3783751D1 (de) | Glyzirrhetinsaeure-derivate und ihre anwendung. | |
FI854800A (fi) | Salter innehaollande 5'-metyltio -5'-deoxiadenocin med laong alkylkedja innehaollande sulfonsyror. | |
NO903759D0 (no) | Substituerte glutaraminsyrer og -derivater. | |
DK425788A (da) | 1,4-disubstituerede 1-azolyl-3,3-dimethylbutanderivater, fremgangsmaade til deres anvendelse samt deres anvendelse | |
DE3883979T2 (de) | Zusammensetzung auf der basis von cyclopolygalakturonsäure und verwendung derselben. | |
NO883857L (no) | 3'-demetoksyepipodofyllotoksin-glukosidderivater. | |
IT1188557B (it) | Acidi 8-osso-2-ossa-1-azabiciclo (4.2.0)ottano-3-carbossilici | |
IT8920483A0 (it) | 10 norantracicline. | |
DE68912083T2 (de) | Substituierte Karbonsäuren, ihre Herstellung und Verwendung. | |
FI890483A (fi) | Foerfarande foer framstaellning av sulfaterade alkanol- eller alkylfenoloxetylater med saenkt 1,4-dioxanhalt. | |
ATE64742T1 (de) | Stark suesse l-aspartyl-3-(bicycloalkyl)-lalaninalkylester. | |
Costopoulos-Almon | Chaucer and Pandarus: co-architects of the Troilus | |
Lord | The Critical Historians of Art | |
Jones | The Dawn's early light; the lessons of the Aurora industrial benefit and offset program. | |
FI871715A0 (fi) | Foerbaettring av svavelextraktion ur jaernmalm behandlat med oxideringsextraktion. | |
IT8764287V0 (it) | Letto ripiegabile su se' stesso. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |